Prognostic features in men who died of prostate cancer
- PMID: 16006890
- DOI: 10.1097/01.ju.0000165184.72337.9d
Prognostic features in men who died of prostate cancer
Abstract
Purpose: Since the advent of widespread prostate specific antigen (PSA) based screening in the United States, the risk of over diagnosis as well as delayed diagnosis due to existing PSA thresholds has become a concern. Treatment decision planning is generally linked to prognostic variables, most notably PSA, clinical stage and Gleason grade. We examined these and other prognostic variables in a cohort of men who ultimately died of prostate cancer.
Materials and methods: Of 413 men with prostate cancer in a cohort in San Antonio, Texas between 1993 and 2003 who died of disease we identified 211 who died as a direct result of prostate cancer. In these cases we assessed presenting symptoms, PSA history, tumor stage and Gleason score at diagnosis.
Results: Of the 211 men 141 (67%) underwent screening for prostate cancer prior to diagnosis. Of 190 men with PSA data at diagnosis available 7 (3.7%) had PSA less than 4.0 ng/ml and 27 (14%) had PSA 4.0 to 10.0 ng/ml. Clinical stage distribution was cT1 in 21.1% of cases, cT2 in 50.7% and cT3 in 26.8%. Of 167 men for whom biopsy Gleason grade was available 16.8%, 16.2%, 24% and 43.1% had Gleason sum 5 or less, 6, 7 and 8 or higher, respectively.
Conclusions: While most men who ultimately die of prostate cancer have poor prognostic features, a substantial number have features associated with a potentially good prognosis, including low PSA and low Gleason grade. Many men who died of prostate cancer had undergone prior screening. These data demonstrate the need for improved markers of prognosis and continued assessment of the efficacy of screening with PSA.
Similar articles
-
Prostate-specific antigen velocity and prostate cancer gleason grade and stage.Cancer. 2007 Apr 15;109(8):1689-95. doi: 10.1002/cncr.22558. Cancer. 2007. PMID: 17330856
-
Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.J Urol. 2001 Nov;166(5):1702-6. J Urol. 2001. PMID: 11586206
-
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x. BJU Int. 2007. PMID: 17229162 Review.
-
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.Urology. 2007 Mar;69(3):515-9. doi: 10.1016/j.urology.2006.11.009. Urology. 2007. PMID: 17382156
-
Prognostic value of serum markers for prostate cancer.Scand J Urol Nephrol Suppl. 2005 May;(216):64-81. doi: 10.1080/03008880510030941. Scand J Urol Nephrol Suppl. 2005. PMID: 16019759 Review.
Cited by
-
[Selection criteria for the expected management of localised prostate cancer].Urologe A. 2005 Nov;44(11):1277-8, 1280-6. doi: 10.1007/s00120-005-0924-3. Urologe A. 2005. PMID: 16205879 Review. German.
-
Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL.Cancer Gene Ther. 2010 Mar;17(3):180-91. doi: 10.1038/cgt.2009.62. Epub 2009 Oct 2. Cancer Gene Ther. 2010. PMID: 19798123 Free PMC article.
-
Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.Clin Cancer Res. 2008 Dec 1;14(23):7790-7. doi: 10.1158/1078-0432.CCR-08-1716. Clin Cancer Res. 2008. PMID: 19047106 Free PMC article.
-
Low risk prostate cancer in men under age 65: the case for definitive treatment.Urol Oncol. 2007 Nov-Dec;25(6):510-4. doi: 10.1016/j.urolonc.2007.05.025. Urol Oncol. 2007. PMID: 18047962 Free PMC article. Review.
-
[The role of surgery in locally advanced prostate cancer].Urologe A. 2008 Nov;47(11):1417-23. doi: 10.1007/s00120-008-1721-6. Urologe A. 2008. PMID: 18820896 German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous